The global infectious disease rapid diagnostic testing market size is expected to reach USD 51.01 Billion in 2030 and register a revenue CAGR of 7.0% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of infectious diseases and emergence of COVID-19 are some key factors driving market revenue growth. Prevalence of infectious diseases has been rising, in both developed and developing countries, and resulting in steady demand for infectious disease rapid diagnostic testing. Following the pandemic, the need to identify and monitor infectious diseases has been placed on significantly high importance and has driven major increase in demand for testing kits. Moreover, rising preference for preventive care is expected to increase need for infectious disease diagnostics over the forecast period. Large-scale population-based testing is necessary to strengthen COVID-19 preventive and control efforts and measures, which is expected to continue to drive increased demand for infectious disease diagnostic products in future.
The Infectious Disease Rapid Diagnostic Testing Market report also offers details about market size, market share, revenue growth, and CAGR during the forecast period. The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.
Competitive Terrain:
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Infectious Disease Rapid Diagnostic Testing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Corporation, BioMérieux SA, BD (Becton, Dickinson, and Company), Siemens Healthineers AG, PerkinElmer Inc., Bio-Rad Laboratories, Inc., and Sysmex Corporation
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/infectious-disease-rapid-diagnostic-testing-market
Emergen Research has segmented the global Infectious Disease Rapid Diagnostic Testing market on the basis of type, application, end-use, and region:
-
Product & Service Outlook (Revenue, USD Billion; 2019–2030)
- Reagent & Kits
- Instruments
- Data Management Software
- Service
-
Technology Outlook (Revenue, USD Billion; 2019–2030)
- Immunoassay
- Enzyme-linked Immunosorbent Assay (ELISA)
- Enzyme-linked Immunospot Assay (ELISpot)
- Polymerize Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Microarray
- Clinical Microbiology
- Other Technologies
- Immunoassay
-
Disease Outlook (Revenue, USD Billion; 2019–2030)
- Hepatitis
- Influenza
- HIV/AIDS
- HPV
- CT/NG
- Tuberculosis
- HAIs
- Covid-19
- Others
The various regions analyzed in the report include:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
- Analysis and estimation of the Infectious Disease Rapid Diagnostic Testing Market size and share for the projected period of 2022-2030
- Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
- Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Infectious Disease Rapid Diagnostic Testing Market
- Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
- Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities